Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Fibromyalgia (FM) is a syndrome characterized by chronic widespread pain and the presence of specific tender points. The prevalence of FM has been estimated at 2-7 % of the general global population. The presence of FM in several rheumatic diseases with a structural pathology has been reported as 11-30 %. The objectives of this study were to determine the prevalence of FM and to evaluate the possible relationship between FM existence and disease activity among rheumatic diseases. The study group included 835 patients--197 rheumatoid arthritis (RA), 67 systemic lupus erythematosus (SLE), 119 ankylosing spondylitis (AS), 238 osteoarthritis (OA), 14 familial Mediterranean fever (FMF), 53 Behçet's disease (BD), 71 gout, 25 Sjögren's syndrome (SS), 20 vasculitis, 29 polymyalgia rheumatica (PMR), and two polymyositis (PM)--with or without FM. Recorded information included age, gender, laboratory parameters, presence of fatigue, and disease activity indexes. The prevalence of FM in patients with rheumatologic diseases was found to be 6.6 % for RA, 13.4 % for SLE, 12.6 % for AS, 10.1 % for OA, 5.7 % for BD, 7.1 % for FMF, 12 % for SS, 25 % for vasculitis, 1.4 % for gout, and 6.9 % for PMR. One out of two patients with PM was diagnosed with FM. Some rheumatologic cases (AS, OA) with FM were observed mostly in female patients (p = 0.000). Also, there were significant correlations between disease activity indexes and Fibromyalgia Impact Questionnaire scores for most rheumatologic patien…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies have examined symptoms of fibromyalgia in inflammatory or autoimmune rheumatic diseases and the relationship with disease activity (1, 2).”
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.554 · Cited by 5,299
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Garrett, S., Jenkinson, T., Kennedy, L. G., Whitelock, H., Gaisford, P., & Călin, A. (1994) · PubMed · Cited by 3,241
Criteria for diagnosis of Behçet's disease
Weichsler, B., Davatchi, F., Lehner, T., O’Duffy, J. D., Rigby, A. S., & Gregory, J. K. (1990) · The Lancet · Cited by 3,082
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.
(1990) · PubMed · Cited by 2,637
Research works printed but not linked: 1
- Azevedo VF, Paiva ES, Felippe LRH, Moreira RA (2010) Occurrence of fibromyalgia in patients with ankylosing spondylitis. Bras J Rheumatol 50(6):646–654
Cited by
The IASP classification of chronic pain for ICD-11: chronic primary pain
Nicholas, M., Vlaeyen, J. W. S., Rief, W., Barke, A., Aziz, Q., Benoliel, R., Cohen, M., Evers, S., Giamberardino, M. A., Goebel, A., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001390 · Cited by 1,424
“a quantitative rather than a qualitative distinction that depends on criteria that have yet to be validated.(20,42) For a case vignette”
BackgroundFibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
AAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M.-A., Paiva, E. S., Staud, R., Sarzi-Puttini, P., et al. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 420
“Various rheumatic conditions, both inflammatory and degenerative, may act as a peripheral pain generator and associate with FM including inflammatory rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, Sjogren’s syndrome and others, and osteoarthritis.(14,23,33,59,80,89,137) Joi…”
BackgroundDeciphering nociplastic pain: clinical features, risk factors and potential mechanisms
Kaplan, C. M., Kelleher, E., Irani, A., Schrepf, A., Clauw, D. J., & Harte, S. E. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00966-8 · Cited by 208
“Similar observations are made among adults with osteoarthritis 105 or other COPCs.”
Chronic Pain: Where the Body Meets the Brain.
Crofford, L. J. (2015) · Europe PMC (PubMed Central) · Cited by 344
Duffield, S. J., Miller, N., Zhao, S., & Goodson, N. J. (2018) · Rheumatology · doi:10.1093/rheumatology/key112 · Cited by 158
de Hair, M. J. H., Jacobs, J. W. G., Schoneveld, J. L. M., & van Laar, J. M. (2017) · Rheumatology · doi:10.1093/rheumatology/kex349 · Cited by 145
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica
Dejaco, C., Kerschbaumer, A., Aletaha, D., Bond, M., Hysa, E., Camellino, D., Ehlers, L., Abril, A., Appenzeller, S., Cid, M. C., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223429 · Cited by 144
“74 In GCA, other causes of headache (eg, migraine, trigeminal neuralgia, tension headache) or visual disturbances need to be distinguished from GCA-related symptoms.”
BackgroundMease, P. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000388 · Cited by 144
Comorbid fibromyalgia: A qualitative review of prevalence and importance
Fitzcharles, M. ‐., Perrot, S., & Häuser, W. (2018) · European Journal of Pain · doi:10.1002/ejp.1252 · Cited by 136
Fibromyalgia: management strategies for primary care providers
Arnold, L. M., Gebke, K. B., & Choy, E. H. S. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12757 · Cited by 112
The complexities of fibromyalgia and its comorbidities
Lichtenstein, A., Tiosano, S., & Amital, H. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000464 · Cited by 119
Moltó, A., Etcheto, A., Gossec, L., Boudersa, N., Claudepierre, P., Roux, N., Lemeunier, L., Martin, A., Sparsa, L., Coquerelle, P., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212378 · Cited by 126
Pain and affective distress in arthritis: relationship to immunity and inflammation
Harth, M., & Nielson, W. R. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1573675 · Cited by 132
Understanding differences between men and women with axial spondyloarthritis
Wright, G. C., Kaine, J., & Deodhar, A. A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.05.005 · Cited by 120
Bello, N., Etcheto, A., Béal, C., Dougados, M., & Moltó, A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0943-z · Cited by 111
“These results are consistent with previous studies [16, 17, 20, 30, 31].”
BackgroundResultThe problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia
Marchesoni, A., Marco, G. D., Merashli, M., McKenna, F., Tinazzi, I., Marzo‐Ortega, H., & McGonagle, D. (2017) · Rheumatology · doi:10.1093/rheumatology/kex079 · Cited by 102
Macfarlane, G. J., Barnish, M. S., Pathan, E., Martin, K. R., Haywood, K. L., Siebert, S., Packham, J., Atzeni, F., & Jones, G. T. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40185 · Cited by 93
“In the above-mentioned study from Turkey in which AS patients with FM and those without FM were compared, there was no difference in the C-reactive protein (CRP) level or erythrocyte sedimentation rate, but those with FM had higher BASDAI scores (3).”
BackgroundIdentifying and Managing Nociplastic Pain in Individuals With Rheumatic Diseases: A Narrative Review
Murphy, A. E., Minhas, D., Clauw, D. J., & Lee, Y. (2023) · Arthritis Care & Research · doi:10.1002/acr.25104 · Cited by 114
The prevalence of fibromyalgia in axial spondyloarthritis
Jones, G. T., Mallawaarachchi, B., Shim, J., Lock, J., & Macfarlane, G. J. (2020) · Rheumatology International · doi:10.1007/s00296-020-04621-5 · Cited by 82
Gergianaki, I., & Bertsias, G. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00161 · Cited by 72
“Its recognition is important for the optimal management of the disease (142, 143).”
BackgroundControversies and challenges in fibromyalgia: a review and a proposal
Cohen, H. (2017) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17699199 · Cited by 87
Wallman, J. K., Kapetanovic, M. C., Petersson, I. F., Geborek, P., & Kristensen, L. E. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0897-6 · Cited by 76
“Furthermore, patient-reported SpA measures are known to differentiate poorly between symptoms related to SpA or CWP [48], with generally worse outcomes among patients with such comorbidity [49, 50], and poorer adherence to anti-TNF therapy was also recently reported in SpA patients with concurrent fibromyalgia [50].”
BackgroundHigh Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete
Gergianaki, I., Garantziotis, P., Adamichou, C., Saridakis, I., Spyrou, G., Sidiropoulos, P. I., & Bertsias, G. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050998 · Cited by 77
“To this end, fibromyalgia, which was not evaluated in our cohort, represents a common SLE comorbidity often correlating with or considered to be part of the spectrum of mental conditions [19].”
BackgroundPatients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis
Baraliakos, X., Regel, A., Kiltz, U., Menne, H.-J., Dybowski, F., Igelmann, M., Kalthoff, L., Krause, D., Saracbasi, E., Schmitz-Bortz, E., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex318 · Cited by 67
Bucourt, E., Martaillé, V., Goupille, P., Joncker-Vannier, I., Huttenberger, B., Réveillère, C., Mulleman, D., & Courtois, A. R. (2021) · Pain Medicine · doi:10.1093/pm/pnz255 · Cited by 63
Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients
Fan, A., Pereira, B., Tournadre, A., Tatar, Z., Malochet‐Guinamand, S., Mathieu, S., Couderc, M., Soubrier, M., & Dubost, J. (2017) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2017.01.005 · Cited by 62
RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
Nasonov, E. L., Olyunin, Y. A., & Lila, A. M. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-263-271 · Cited by 62
Sarah El-Rabbat, M., Mahmoud, N. K., & Gheita, T. A. (2017) · Reumatología Clínica · doi:10.1016/j.reuma.2017.02.008 · Cited by 60
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia
Berger, A. A., Keefe, J., Winnick, A. A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.08.010 · Cited by 67
Sandıkçı, S. C., & Özbalkan, Z. (2015) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2015.0029 · Cited by 57
“Symptoms of fibromyalgia such as increased pain, physical limitations, and fatigue may be mistaken for those of several inflammatory and autoimmune rheumatologic disorders, especially during increased activity of these diseases (52).”
BackgroundThe prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis
Hill, J. E., Harrison, J., Christian, D. L., Reed, J., Clegg, A. J., Duffield, S. J., Goodson, N. J., & Marson, T. (2022) · British Journal of Community Nursing · doi:10.12968/bjcn.2022.27.5.232 · Cited by 55
Pain without inflammation in rheumatic diseases
Lampa, J. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101439 · Cited by 49
Fan, A., Tournadre, A., Pereira, B., Tatar, Z., Couderc, M., Malochet‐Guinamand, S., Mathieu, S., Soubrier, M., & Dubost, J. (2016) · Rheumatology · doi:10.1093/rheumatology/kew244 · Cited by 51
Comorbidities (excluding lymphoma) in Sjögren’s syndrome
Pego‐Reigosa, J. M., Vélez, J. R., Baldini, C., & de Larrinoa, Í. R.-F. F. (2018) · Rheumatology · doi:10.1093/rheumatology/key329 · Cited by 44
Comorbidities in spondyloarthritis including psoriatic arthritis
Moltó, A., & Dougados, M. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.09.002 · Cited by 47
Benlidayı, İ. C. (2020) · Rheumatology International · doi:10.1007/s00296-019-04506-2 · Cited by 45
Rogers, J. L., Eudy, A. M., Pisetsky, D. S., Criscione‐Schreiber, L. G., Sun, K., Doss, J., & Clowse, M. E. B. (2021) · Arthritis Care & Research · doi:10.1002/acr.24135 · Cited by 40
“The rate of fibromyalgia in SLE is significantly greater than the 2–6% rate reported in the general population (26,33,34) and is similar to a recent pooled meta-analysis in rheumatoid arthritis (35); the rate for lupus is also greater than that in other rheumatic diseases such as psoriatic arthritis or axial spondyloa…”
ResultSalaffi, F., Carlo, M. D., Carotti, M., & Sarzi‐Puttini, P. (2018) · Rheumatology International · doi:10.1007/s00296-018-4096-z · Cited by 40
Rúa‐Figueroa, Í., Castro, M. F., Andreu, J. L., Sánchez‐Piedra, C., Martínez‐Taboada, V., Olivé, A., López‐Longo, J., Rosas, J., Galindo-Izquierdo, M., Alén, J. C., et al. (2016) · Arthritis Care & Research · doi:10.1002/acr.23015 · Cited by 37
Bergman, S., Thorstensson, C. A., & Andersson, M. (2019) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-019-2976-3 · Cited by 39
“The difference could depend on that the diagnose was self-reported in the present study and not evaluated by clinical examination [2].”
BackgroundResultInfluentialWhiteside, N., Sarmanova, A., Chen, X., Zou, K., Abdullah, N., Doherty, M., & Zhang, W. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3948-3 · Cited by 35
“This is not unexpected as both fibromyalgia and osteoarthritis are characterised by chronic pain, restricted function and fatigue, and often show some commonalities in terms of central pain sensitisation [17].”
BackgroundPardo, F. L., Bondesson, E., Schelin, M. E. C., & Jöud, A. (2019) · European Journal of Pain · doi:10.1002/ejp.1432 · Cited by 36
D’Onghia, M., Ciaffi, J., McVeigh, J. G., Martino, A. C. D., Faldini, C., Ablin, J. N., Melicòni, R., & Ursini, F. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.05.016 · Cited by 34
Fitzcharles, M., Brachaniec, M., Cooper, L., Dubin, R. E., Flynn, T., Gerhold, K., Häuser, W., Cowan, K., Laupacis, A., Marleau, R., et al. (2017) · Canadian Journal of Pain · doi:10.1080/24740527.2017.1374820 · Cited by 35
Magro, R., & Borg, A. (2018) · BioMed Research International · doi:10.1155/2018/2385386 · Cited by 34
The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures
Alunno, A., Carubbi, F., Stones, S. R., Gerli, R., Giacomelli, R., & Baraliakos, X. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00290 · Cited by 33
Mahgoub, M. Y., Elnady, B., Abdelkader, H. S., Abdelhalem, R. A., & Hassan, W. A. (2020) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s252748 · Cited by 27
Güler, T., Garip, Y., Dörtbaş, F., & Dogan, Y. P. (2017) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2017.07.004 · Cited by 26
Mogård, E., Bremander, A., Lindqvist, E., & Bergman, S. (2018) · BMC Rheumatology · doi:10.1186/s41927-018-0018-7 · Cited by 26
Martinis, F., Tinazzi, I., Bertolini, E., Citriniti, G., Variola, A., Geccherle, A., Marchetta, A., McGonagle, D. G., & Macchioni, P. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa036 · Cited by 26
Mülkoğlu, C., & Ayhan, F. F. (2020) · Modern Rheumatology · doi:10.1080/14397595.2020.1823069 · Cited by 27
“These results are consistent with previous studies [3,9].”
ResultKoçyiğit, B. F., & Akyol, A. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06385-8 · Cited by 28
“The definitive prevalence of this accompanying FMS in IRDs remains a matter of debate [4].”
BackgroundUlus, Y., Akyol, Y., Bilgici, A., & Kuru, Ö. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0104-6 · Cited by 24
Rheumatoid arthritis: achievements and unresolved issues
Nasonov, E. L., & Lila, A. M. (2019) · Terapevticheskii arkhiv · doi:10.26442/00403660.2019.05.000259 · Cited by 24
Sağlam, G. (2019) · Pain Physician · doi:10.36076/ppj/2019.22.e579 · Cited by 22
“Similar to our study, Haliloglu et al (19) determined that Bath Ankylosing Spondylitis Disese Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) scores were affected by the presence of FMS in patients with AS and scores were higher in AS patients with concomitant FMS.”
BackgroundResultAzarfar, A., Ahmed, A., & Bég, S. (2020) · Current Rheumatology Reviews · doi:10.2174/1573397116666201211124815 · Cited by 23
Ambroxol for the treatment of fibromyalgia: science or fiction?
Kern, K., & Schwickert, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s139223 · Cited by 22
Fibromyalgia in Axial Spondyloarthritis: A Meta-analysis
Son, S. M., Kim, D. S., & Lee, J. S. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001612 · Cited by 21
“The prevalence of FM is estimated to be between 2% and 7% in the general population(9) and has frequently been associated with some rheumatic diseases.(4,6) Moltó et al(6) showed that the prevalence rate of FM in patients with AxSpA in their study was as high as 38.”
BackgroundRivera, J., Rodríguez, T., Pallarés, M. G., Castrejón, I., González, T. L., Vallejo-Slocker, L., Collada, J. M., Montero, F., Arias, A., Vallejo, M. Á., et al. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05436-0 · Cited by 21
“Since the global prevalence of FM in the main inflammatory and autoimmune diseases is high [33], the evaluation of the principal variables in this group of patients may be biased.”
BackgroundTreat‐to‐Target Strategy for Fibromyalgia: Opening the Dialogue
Häuser, W., Clauw, D. J., & Fitzcharles, M. (2016) · Arthritis Care & Research · doi:10.1002/acr.22970 · Cited by 20
Dubost, J., Couderc, M., Pereira, B., Mariette, X., Séror, R., Gottenberg, J., HACHULLA, E., Guern, V. L., Saraux, A., Morel, J., et al. (2021) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/uxlsh3 · Cited by 20
Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis
Shresher, N. M., Mohamed, A. E., & Elshahaly, M. H. (2019) · Rheumatology International · doi:10.1007/s00296-019-04403-8 · Cited by 21
Koppert, T. Y., Jacobs, J. W. G., Lumley, M. A., & Geenen, R. (2021) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2021.110655 · Cited by 19
“Another limitation is that CSS conditions were not confirmed by clinical assessment, which may have underestimated CSS in, for instance, rheumatic diseases [53].”
Mistry, S., Daoud, A., Magrey, M., & Pamuk, O. N. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07188-9 · Cited by 18
“This suggests that SLE disease activity may be correlated with FM. Conversely, a literature review indicated that FM does not correlate directly with SLE disease activity [3, 7, 14, 31, 36, 48, 68].”
Early Diagnosis of Fibromyalgia Using Surface-Enhanced Raman Spectroscopy Combined with Chemometrics
Bao, H., Hackshaw, K. V., Castellví, S. D. L., Wu, Y., Gonzalez, C. M., Nuguri, S. M., Yao, S., Goetzman, C. M., Schultz, Z. D., Yu, L., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010133 · Cited by 17
Faria, D. S., Dougados, M., Gossec, L., Perrot, S., & Moltó, A. (2018) · Rheumatology International · doi:10.1007/s00296-018-4200-4 · Cited by 17
Tesher, M. S., Graham, T. B., Ting, T. V., Kashikar‐Zuck, S., Lynch, N., Wroblewski, K., & Weiss, J. E. (2021) · Arthritis Care & Research · doi:10.1002/acr.24739 · Cited by 17
“Sex Female 99 (77) Male 29 (22) Not reported 1 (1) Race/ethnicity White non-Hispanic 96 (74) Hispanic 14 (11) African American 4 (3) Asian 5 (4) Other 4 (3) Not reported 6 (5) Age, mean ± SD (median) years 14.”
BackgroundKoy, E. H. S., Labauge, P. M., Baillet, A. C., Prati, C., Marotte, H., & Pers, Y. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211025894 · Cited by 20
Vela, J., Dreyer, L., Petersen, K. K., Arendt‐Nielsen, L., Duch, K. S., Amris, K., & Kristensen, S. (2023) · European Journal of Pain · doi:10.1002/ejp.2183 · Cited by 16
“No previous studies have examined the proportion of cFM among patients with hand-OA, but the prevalence is estimated to be 10% to 35% (Dzekan & Stanislavchuk, 2018; Haliloglu et al., 2014; Mahgoub et al., 2020) in patients with knee-OA.”
BackgroundMoore, T., Sodhi, N., Kalsi, A., Vakharia, R. M., Ehiorobo, J. O., Anis, H. K., Dushaj, K., Papas, P. V., Scuderi, G. R., Nelson, S. R., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.60 · Cited by 15
“The relationship between fibromyalgia and rheumatic diseases is well-established (5-7) and this comorbidity is estimated to be between 11% and 30% (6).”
BackgroundJiao, J., Davis, J. M., Cha, S., Luedtke, C. C., Vincent, A., & Oh, T. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1052553 · Cited by 15
Petersen, M. W., Skovenborg, E. L., Rask, C. U., Høeg, M. D., Ørnbøl, E., & Schröder, A. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.11.005 · Cited by 15
Central sensitisation in primary Sjögren Syndrome and its effect on sleep quality
Ökmen, B. M., Ayar, K., Altan, L., & Yeşilöz, Ö. (2021) · Modern Rheumatology · doi:10.1093/mr/roab075 · Cited by 13
Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment
Bouden, S., Saidane, O., Sahli, M., Tekaya, A. B., Rouached, L., Rawdha, T., Mahmoud, I., & ABDELMOULA, L. (2022) · Current Rheumatology Reviews · doi:10.2174/1573397118666220902100151 · Cited by 15
Vidal, C., Lukas, C., Combe, B. G., Berenbaum, F., Pers, Y., Jørgensen, C., Sellam, J., & Morel, J. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.08.005 · Cited by 12
Meesters, J. J., Bergman, S., Haglund, E., Jacobsson, L., Petersson, I. F., & Bremander, A. (2017) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2017.1350744 · Cited by 14
Shapoval, I., & Stanislavchuk, M. (2022) · Rheumatology International · doi:10.1007/s00296-022-05168-3 · Cited by 12
“Doctors that take part in FM management should be aware of possible inflammatory changes and actively search for such concomitant diseases [24, 26].”
BackgroundDiagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity
Kılıçarslan, A., Yurdakul, F. G., & Bodur, H. (2018) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2018.1618 · Cited by 13
Sarah El-Rabbat, M., Mahmoud, N. K., & Gheita, T. A. (2018) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2017.02.007 · Cited by 11
Soni, A., Nishtala, R., Ng, S., Barnett, R., Chyou, T., Cavill, C., & Sengupta, R. (2022) · Rheumatology · doi:10.1093/rheumatology/keac679 · Cited by 12
Denvir, B., Carlucci, P. M., Corbitt, K., Buyon, J. P., Belmont, M. H., Gold, H. T., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino-Pardilla, L. B., et al. (2024) · Frontiers in Epidemiology · doi:10.3389/fepid.2024.1334859 · Cited by 9
Fibromyalgia in Behçet’s disease: a narrative review
Jobanputra, C., Richey, R. H., Nair, J. R., Moots, R. J., & Göebel, A. (2017) · British Journal of Pain · doi:10.1177/2049463717701393 · Cited by 9
Evaluating amitriptyline’s role in chronic TMD management: a placebo-controlled trial
Brakus, R. B., Brakus, I., Carek, A. J., Galić, T., & Alajbeg, I. Z. (2025) · BMC Oral Health · doi:10.1186/s12903-025-05670-7 · Cited by 9
“Patients with chronic pain, particularly those with conditions like inflammatory or degenerative joint disease, are more susceptible to developing centrally triggered pain, such as fibromyalgia, which occurs at a fourfold higher rate in these patients [20].”
Saygın, D., Malfait, A., Ritz, E. M., Wipfler, K., Michaud, K. D., & Lee, Y. (2025) · Arthritis Care & Research · doi:10.1002/acr.25571 · Cited by 8
“14 Even though Raynaud phenomenon and other comorbidities such as osteoarthritis may contribute to pain experienced by patients with IIM, no signi fi cant differences were observed for the frequencies of osteoarthritis and Raynaud phenomenon in patients who had signi fi cant pain versus those who did…”
Relationship between mean platelet volume and vitamin D deficiency in fibromyalgia
Yıldırım, T., Solmaz, D., Akgöl, G., & Ersoy, Y. (2016) · DSpace - FIRAT (Fırat University) · Cited by 14
Magrey, M., Thomas, C. L., & Khan, M. A. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001490 · Cited by 8
Manzo, C., Nizama‐Vía, A., Milchert, M., Isetta, M., Castagna, A., Natale, M., & Mestres, J. S. (2020) · Reumatologia/Rheumatology · doi:10.5114/reum.2020.102003 · Cited by 8
Cebranopadol for the Treatment of Chronic Pain
Edinoff, A. N., Flanagan, C. J., Roberts, L. T., Dies, R., Kataria, S., Jackson, E. D., DeWitt, A. J., Wenger, D. M., Cornett, E. M., Kaye, A. M., et al. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01148-9 · Cited by 9
“Fibromyalgia, which is a musculoskeletal, central pain amplification syndrome, is increasingly common in patients who already have been diagnosed with another disorder, such as degenerative joint disease [14].”
BackgroundInterdisciplinary assessment-oriented treatment of fibromyalgia: a case report
Romeyke, T., Nöhammer, E., & Stummer, H. (2018) · Integrative Medicine Research · doi:10.1016/j.imr.2018.02.002 · Cited by 6
Klemm, P., Hudowenz, O., Asendorf, T., Dischereit, G., Müller‐Ladner, U., Lange, U., & Tarner, I. H. (2020) · European Journal of Physiotherapy · doi:10.1080/21679169.2020.1821767 · Cited by 7
Nacar, N. E., Argut, S. K., & Ünal, E. (2025) · Disability and Rehabilitation · doi:10.1080/09638288.2025.2474085 · Cited by 7
“Studies have shown that the prevalence of fibromyalgia associated with chronic pain in Sjögren’s syndrome ranges from 12% to 31% [4,5].”
Gibson, K., Kaplan, R. M., Pincus, T., Li, T., & Luta, G. (2024) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2024.152361 · Cited by 6
Stano, S., Venerito, V., Domanico, D., Iacovantuono, M., Urgesi, E., Cacciapaglia, F., Giannotta, M. G., Fornaro, M., Conigliaro, P., Vitale, A., et al. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04193-x · Cited by 6
“The coexistence of FM is being increasingly recognized across autoimmune diseases, including RA, SpA, SLE, and systemic sclerosis (SSc) [21, 22].”
Miladi, S., Ayed, H. B., Fazaa, A., Boussaa, H., Makhlouf, Y., Souabni, L., Ouenniche, K., Kassab, S., Chekili, S., Abdelghani, K. B., et al. (2023) · Musculoskeletal Care · doi:10.1002/msc.1779 · Cited by 6
Rubano, A., Jiroutek, M. R., & Misciagno, S. A. (2025) · BMC Rheumatology · doi:10.1186/s41927-025-00483-1 · Cited by 6
“…is not consistent with previous research as noted by Halilo-glu, et al. whom observed the prevalence of fibromyalgia in patients with other rheumatological diseases such as lupus, Sjögren’s disease, and osteoarthritis (amongst others related diseases) to be a clinical common problem in FM [22].”
Xiang, Y., Jiao, R., Cao, Y., Liang, D., Zhang, W., Yu, Y., Zhang, W., & Li, C. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05394-9 · Cited by 6
Durmaz, Y., & İlhanlı, İ. (2021) · Turkish Journal of Physical Medicine and Rehabilitation · doi:10.5606/tftrd.2021.7796 · Cited by 6
“Similar to our study, in the literature, these disease activity scores were positively correlated in patients with SpA.[20,23] Although the acute phase reactants were taken into account while calculating both ASDAS-ESR and ASDAS-CRP, the correlation between them was moderate in AS patients with FM in our study, and th…”
BackgroundResultValidation of SIMPLE Index for Lupus Disease Activity
Gandhi, N., Arora, S. K., Sengupta, M., Sequeira, W., Jolly, M., & Block, J. A. (2018) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000738 · Cited by 6
“4% of SLE patients.(26) Not surprisingly, severity of FM symptoms measured by the FM Impact Questionnaire also correlates with rheumatic disease activitymeasured by standardized tools including in patients with SLE.”
BackgroundAyar, K., Ökmen, B. M., Altan, L., & ÖZTÜRK, E. K. (2020) · Archives of Rheumatology · doi:10.46497/archrheumatol.2020.7729 · Cited by 6
Metadata
- Authors
- Haliloglu, S., Carlioglu, A., Akdeniz, D., Karaaslan, Y., & Kosar, A.
- Affiliations
- Fatih University (TR)
- Venue
- Rheumatology International
- Published
- 2014-03-04
- Volume
- 34
- Issue
- 9
- Pages
- 1275-1280
- ISSN
- 0172-8172 (ISSN-L)
- 1437-160X
- OpenAlex
- W2056108471
- Cited by
- 181
- References
- 44
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 16 · 2023: 12 · 2022: 16 · 2021: 21 · 2020: 18 · 2019: 16 · 2018: 19 · 2017: 23 · 2016: 10 · 2015: 5 · 2014: 1
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Rheumatology International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Myofascial pain diagnosis and treatment
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Keywords
- fibromyalgia, comorbidities, rheumatic diseases, prevalence, disease activity, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, osteoarthritis, Behçet's disease, vasculitis, polymyalgia rheumatica, polymyositis, fatigue, Fibromyalgia Impact Questionnaire, sex differences
- MeSH terms
- Adolescent, Adult, Aged, Female, Fibromyalgia, Humans, Male, Middle Aged, Pain Measurement, Prognosis, Surveys and Questionnaires, Rheumatic Diseases, Severity of Illness Index, Turkey, Comorbidity, Prevalence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.